J&J Weighs Third Bankruptcy Try to Settle Baby Powder Suits

DEA Loosens ADHD Drug Production Controls Amid Shortage

Blackstone, Airbnb to Join S&P 500 After Index Rebalancing

Ozempic Could Be The Next Target of Medicare Price Negotiations

3M Agrees to Pay More Than $5.5 Billion Over Military Earplugs

J&J, Cancer Victims Agree to Quick Appeal of Bankruptcy Ruling

Asia Stocks Set to Follow Bullish Wall Street Mood: Markets Wrap

Tylenol Maker Kenvue Sinks on Looming J&J Exchange Offer

J&J Ordered to Pay $18.8 Million Over Man’s Talc-Cancer Claims

FDA Revokes Authorization of J&J’s Covid Vaccine as Demand Wanes

J&J’s $8.9 Billion Talc Deal Faces Key Test in Oakland Trial